RS1976391 Unknown gene
Upload your DNA to see your genotype for this variant.
GWAS Studies (17)
| Trait | Risk Allele | OR / Beta | P-value | Study |
|---|---|---|---|---|
| Bilirubin (z,z) levels | A | OR: 0.7 | 8E-957 | PubMed |
| Biliverdin levels | A | OR: 0.65 | 2E-802 | PubMed |
| Bilirubin (E,E) levels | A | OR: 0.64 | 6E-774 | PubMed |
| X-11530 levels | A | OR: 0.54 | 1E-542 | PubMed |
| X-11522 levels | A | OR: 0.53 | 3E-541 | PubMed |
| Jaundice (not of newborn) (PheCode 573.5) | A | OR: 0.72 | 6E-159 | PubMed |
| Jaundice (not of newborn) (PheCode 573.5) | A | OR: 0.78 | 2E-135 | PubMed |
| Tissue factor levels | A | OR: 0.19 | 2E-42 | PubMed |
| Metabolite peak levels (QI11739) | G | OR: 0.36 | 6E-34 | PubMed |
| X-21796 levels | A | OR: 0.12 | 5E-29 | PubMed |
| total cholesterol (mean, inv-norm transformed) | A | β: 0.023 | 2E-19 | PubMed |
| Cerebrospinal fluid unidentified metabolite levels (HILIC Metabolomics ID: 1.04_583.26) | — | OR: 0.4 | 4E-17 | PubMed |
| Serum metabolite concentrations in chronic kidney disease | — | OR: 0.42 | 4E-17 | PubMed |
| Androstenediol levels | G | OR: 0.44 | 1E-15 | PubMed |
| Cerebrospinal fluid bilirubin (E,E)* levels | A | β: 0.056 | 6E-13 | PubMed |
| Cerebrospinal fluid unidentified metabolite levels (HILIC Metabolomics ID: 1.05_584.26) | — | OR: 0.33 | 7E-12 | PubMed |
| Biliverdin levels | G | OR: 0.39 | 1E-8 | PubMed |